Annual short term debt:
$2.68B-$2.72B(-50.44%)Summary
- As of today (May 29, 2025), AZN annual short term debt is $2.68 billion, with the most recent change of -$2.72 billion (-50.44%) on December 31, 2024.
- During the last 3 years, AZN annual short term debt has risen by +$783.00 million (+41.36%).
- AZN annual short term debt is now -51.71% below its all-time high of $5.54 billion, reached on December 31, 2022.
Performance
AZN Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$3.41B(NaN%)Summary
- As of today (May 29, 2025), AZN quarterly short term debt is $3.41 billion
- Over the past year, AZN quarterly short term debt has dropped by -$2.92 billion (-46.20%).
- AZN quarterly short term debt is now -76.25% below its all-time high of $14.34 billion, reached on June 30, 2007.
Performance
AZN quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AZN Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.4% | -46.2% |
| 3 y3 years | +41.4% | +48.5% |
| 5 y5 years | +33.1% | +37.9% |
AZN Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.7% | +41.4% | -46.2% | +116.9% |
| 5 y | 5-year | -51.7% | +41.4% | -46.2% | +116.9% |
| alltime | all time | -51.7% | +2873.3% | -76.3% | +6075.6% |
AZN Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.41B(+116.9%) |
| Dec 2024 | $2.68B(-50.4%) | - |
| Sep 2024 | - | $1.57B(-70.7%) |
| Jun 2024 | - | $5.36B(-15.4%) |
| Mar 2024 | - | $6.33B(+12.9%) |
| Dec 2023 | $5.40B(-2.6%) | - |
| Sep 2023 | - | $5.61B(+17.1%) |
| Jun 2023 | - | $4.79B(+24.1%) |
| Mar 2023 | - | $3.86B(-29.3%) |
| Dec 2022 | $5.54B(+192.8%) | $5.45B(-2.9%) |
| Sep 2022 | - | $5.62B(+135.9%) |
| Jun 2022 | - | $2.38B(+3.8%) |
| Mar 2022 | - | $2.29B(+27.4%) |
| Dec 2021 | $1.89B(-20.7%) | $1.80B(-39.5%) |
| Sep 2021 | - | $2.97B(+2.7%) |
| Jun 2021 | - | $2.89B(+28.2%) |
| Mar 2021 | - | $2.26B(-5.4%) |
| Dec 2020 | $2.39B(+18.7%) | $2.39B(-33.4%) |
| Sep 2020 | - | $3.58B(-13.2%) |
| Jun 2020 | - | $4.13B(+67.3%) |
| Mar 2020 | - | $2.47B(+22.9%) |
| Dec 2019 | $2.01B(+14.6%) | $2.01B(+248.4%) |
| Sep 2019 | - | $577.00M(-68.6%) |
| Jun 2019 | - | $1.83B(-50.7%) |
| Mar 2019 | - | $3.72B(+112.0%) |
| Dec 2018 | $1.75B(-21.9%) | $1.75B(-29.6%) |
| Sep 2018 | - | $2.49B(-40.9%) |
| Jun 2018 | - | $4.21B(+1.1%) |
| Mar 2018 | - | $4.17B(+85.6%) |
| Dec 2017 | $2.25B(-2.6%) | $2.25B(+138.8%) |
| Sep 2017 | - | $941.00M(-67.9%) |
| Jun 2017 | - | $2.93B(+3.3%) |
| Mar 2017 | - | $2.84B(+23.1%) |
| Dec 2016 | $2.31B(+151.9%) | $2.31B(-21.5%) |
| Sep 2016 | - | $2.94B(+177.3%) |
| Jun 2016 | - | $1.06B(-51.1%) |
| Mar 2016 | - | $2.17B(+136.7%) |
| Dec 2015 | $916.00M(-62.6%) | $916.00M(-65.7%) |
| Sep 2015 | - | $2.67B(-1.3%) |
| Jun 2015 | - | $2.71B(+17.7%) |
| Mar 2015 | - | $2.30B(-6.0%) |
| Dec 2014 | $2.45B(+36.8%) | $2.45B(+2.0%) |
| Sep 2014 | - | $2.40B(-4.0%) |
| Jun 2014 | - | $2.50B(-10.3%) |
| Mar 2014 | - | $2.79B(+55.9%) |
| Dec 2013 | $1.79B(+98.4%) | $1.79B(+4.6%) |
| Sep 2013 | - | $1.71B(-9.1%) |
| Jun 2013 | - | $1.88B(+111.5%) |
| Mar 2013 | - | $889.00M(-1.3%) |
| Dec 2012 | $901.00M(-54.7%) | $901.00M(-42.5%) |
| Sep 2012 | - | $1.57B(-22.0%) |
| Jun 2012 | - | $2.01B(+0.1%) |
| Mar 2012 | - | $2.01B(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $1.99B(+1492.0%) | $1.99B(-3.2%) |
| Sep 2011 | - | $2.06B(+452.4%) |
| Jun 2011 | - | $372.00M(-14.5%) |
| Mar 2011 | - | $435.00M(+248.0%) |
| Dec 2010 | $125.00M(-93.5%) | $125.00M(-90.9%) |
| Sep 2010 | - | $1.38B(+7.9%) |
| Jun 2010 | - | $1.27B(-0.2%) |
| Mar 2010 | - | $1.28B(-33.7%) |
| Dec 2009 | $1.93B(+94.0%) | $1.93B(+96.5%) |
| Sep 2009 | - | $980.00M(-34.6%) |
| Jun 2009 | - | $1.50B(-8.0%) |
| Mar 2009 | - | $1.63B(+63.9%) |
| Dec 2008 | $993.00M(-76.8%) | $993.00M(-61.0%) |
| Sep 2008 | - | $2.55B(-33.7%) |
| Jun 2008 | - | $3.84B(-1.2%) |
| Mar 2008 | - | $3.89B(-9.2%) |
| Dec 2007 | $4.28B(+3047.1%) | $4.28B(-20.8%) |
| Sep 2007 | - | $5.40B(-62.3%) |
| Jun 2007 | - | $14.34B(>+9900.0%) |
| Mar 2007 | - | $59.00M(-56.6%) |
| Dec 2006 | $136.00M(+51.1%) | $136.00M(+20.4%) |
| Sep 2006 | - | $113.00M(+32.9%) |
| Jun 2006 | - | $85.00M(-37.5%) |
| Mar 2006 | - | $136.00M(+51.1%) |
| Dec 2005 | $90.00M(-36.6%) | $90.00M(-26.2%) |
| Sep 2005 | - | $122.00M(-18.7%) |
| Jun 2005 | - | $150.00M(+66.7%) |
| Mar 2005 | - | $90.00M(-36.6%) |
| Dec 2004 | $142.00M(-6.6%) | $142.00M(-16.5%) |
| Sep 2004 | - | $170.00M(+66.7%) |
| Jun 2004 | - | $102.00M(+41.7%) |
| Mar 2004 | - | $72.00M(-52.6%) |
| Dec 2003 | $152.00M(-70.5%) | $152.00M(+175.6%) |
| Jun 2003 | - | $55.15M(-89.3%) |
| Dec 2002 | $516.00M(+60.7%) | $516.00M(+7.8%) |
| Jun 2002 | - | $478.71M(+49.1%) |
| Dec 2001 | $321.00M(+50.3%) | $321.00M(+21.2%) |
| Jun 2001 | - | $264.94M(+24.0%) |
| Dec 2000 | $213.59M(-43.6%) | $213.59M(-51.9%) |
| Jun 2000 | - | $444.06M(+17.2%) |
| Dec 1999 | $379.00M(+0.5%) | $379.00M(-0.8%) |
| Sep 1999 | - | $382.00M(-43.7%) |
| Jun 1999 | - | $678.00M(+79.8%) |
| Dec 1998 | $377.00M(+22.0%) | $377.00M(-24.0%) |
| Jun 1998 | - | $496.00M(+60.4%) |
| Dec 1997 | $309.13M(-22.2%) | $309.13M(-22.2%) |
| Dec 1996 | $397.30M(-5.1%) | $397.30M(-5.1%) |
| Dec 1995 | $418.75M(+20.7%) | $418.75M(-12.5%) |
| Jun 1995 | - | $478.40M(+37.8%) |
| Dec 1994 | $347.08M(-65.7%) | $347.08M(-65.7%) |
| Dec 1993 | $1.01B(-51.7%) | $1.01B |
| Dec 1992 | $2.10B(+946.9%) | - |
| Dec 1991 | $200.22M(+12.8%) | - |
| Dec 1990 | $177.46M | - |
FAQ
- What is AstraZeneca annual short term debt?
- What is the all time high annual short term debt for AstraZeneca?
- What is AstraZeneca annual short term debt year-on-year change?
- What is AstraZeneca quarterly short term debt?
- What is the all time high quarterly short term debt for AstraZeneca?
- What is AstraZeneca quarterly short term debt year-on-year change?
What is AstraZeneca annual short term debt?
The current annual short term debt of AZN is $2.68B
What is the all time high annual short term debt for AstraZeneca?
AstraZeneca all-time high annual short term debt is $5.54B
What is AstraZeneca annual short term debt year-on-year change?
Over the past year, AZN annual short term debt has changed by -$2.72B (-50.44%)
What is AstraZeneca quarterly short term debt?
The current quarterly short term debt of AZN is $3.41B
What is the all time high quarterly short term debt for AstraZeneca?
AstraZeneca all-time high quarterly short term debt is $14.34B
What is AstraZeneca quarterly short term debt year-on-year change?
Over the past year, AZN quarterly short term debt has changed by -$2.92B (-46.20%)